Login Register Cart 0
Generic placeholder image

Current Alzheimer Research

Editor-in-Chief

ISSN (Print): 1567-2050
ISSN (Online): 1875-5828

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Is Vitamin D Supplementation a Danger to Potential Treatments of Alzheimer’s Disease Treatment?

Author(s): Pei-Yun Shih, Su-Boon Yong, Chin-Ming Liu and James Cheng-Chung Wei*

Volume 20, Issue 2, 2023

Published on: 07 June, 2023

Page: [59 - 62] Pages: 4

DOI: 10.2174/1567205020666230530095421

Price: $65

« Previous Next »
[1]
Scheltens P, De Strooper B, Kivipelto M, et al. Alzheimer’s disease. Lancet 2021; 397(10284): 1577-90.
[http://dx.doi.org/10.1016/S0140-6736(20)32205-4] [PMID: 33667416]
[2]
Venigalla M, Sonego S, Gyengesi E, Sharman MJ, Münch G. Novel promising therapeutics against chronic neuroinflammation and neurodegeneration in Alzheimer’s disease. Neurochem Int 2016; 95: 63-74.
[http://dx.doi.org/10.1016/j.neuint.2015.10.011] [PMID: 26529297]
[3]
Rajesh Y, Kanneganti TD. Innate immune cell death in neuroinflammation and alzheimer’s disease. Cells 2022; 11(12): 1885.
[http://dx.doi.org/10.3390/cells11121885] [PMID: 35741014]
[4]
Silva MVF, Loures CMG, Alves LCV, de Souza LC, Borges KBG, Carvalho MG. Alzheimer’s disease: Risk factors and potentially protective measures. J Biomed Sci 2019; 26(1): 33.
[http://dx.doi.org/10.1186/s12929-019-0524-y] [PMID: 31072403]
[5]
Melo van Lent D, Egert S, Wolfsgruber S, et al. Low serum vitamin D status is associated with incident alzheimer’s dementia in the oldest old. Nutrients 2022; 15(1): 61.
[http://dx.doi.org/10.3390/nu15010061] [PMID: 36615719]
[6]
Kang J, Park M, Lee E, Jung J, Kim T. The role of Vitamin D in Alzheimer’s Disease: A transcriptional regulator of amyloidopathy and gliopathy. Biomedicines 2022; 10(8): 1824.
[http://dx.doi.org/10.3390/biomedicines10081824] [PMID: 36009371]
[7]
Mehrabadi S, Sadr SS. Administration of Vitamin D 3 and E supplements reduces neuronal loss and oxidative stress in a model of rats with Alzheimer’s disease. Neurol Res 2020; 42(10): 862-8.
[http://dx.doi.org/10.1080/01616412.2020.1787624] [PMID: 32627720]
[8]
Cui X, Eyles DW. Vitamin D and the central nervous system: Causative and preventative mechanisms in brain disorders. Nutrients 2022; 14(20): 4353.
[http://dx.doi.org/10.3390/nu14204353] [PMID: 36297037]
[9]
Miller BJ, Whisner CM, Johnston CS, Vitamin D. Vitamin D supplementation appears to increase plasma Aβ40 in vitamin D insufficient older adults: A pilot randomized controlled trial. J Alzheimers Dis 2016; 52(3): 843-7.
[http://dx.doi.org/10.3233/JAD-150901] [PMID: 27031473]
[10]
Lin J, Niu Z, Xue Y, et al. Chronic vitamin D3 supplementation alleviates cognition impairment via inhibition of oxidative stress regulated by PI3K/AKT/Nrf2 in APP/PS1 transgenic mice. Neurosci Lett 2022; 783: 136725.
[http://dx.doi.org/10.1016/j.neulet.2022.136725] [PMID: 35697158]
[11]
Pettersen JA. Does high dose vitamin D supplementation enhance cognition?: A randomized trial in healthy adults. J Neurol Neurosurg Psychiatry 2017; 90: 90-7.
[12]
Wang R, Wang W, Hu P, Zhang R, Dong X, Zhang D. Association of dietary vitamin D Intake, Serum 25(OH)D3, 25(OH)D2 with cognitive performance in the elderly. Nutrients 2021; 13(9): 3089.
[http://dx.doi.org/10.3390/nu13093089] [PMID: 34578965]
[13]
Jia J, Hu J, Huo X, Miao R, Zhang Y, Ma F. Effects of vitamin D supplementation on cognitive function and blood Aβ-related biomarkers in older adults with Alzheimer’s disease: A randomised, double-blind, placebo-controlled trial. J Neurol Neurosurg Psychiatry 2019; 90(12): jnnp-2018-320199.
[http://dx.doi.org/10.1136/jnnp-2018-320199] [PMID: 31296588]
[14]
Du Y, Liang F, Zhang L, Liu J, Dou H, Vitamin D. Vitamin D supplement for prevention of Alzheimer’s Disease: A systematic review and meta-analysis. Am J Ther 2021; 28(6): e638-48.
[http://dx.doi.org/10.1097/MJT.0000000000001302] [PMID: 33395056]
[15]
Gil MV, Avedillo SA, Santander BS. Vitamin supplementation and dementia: A systematic review. Nutrients 2022; 14(5): 1033.
[http://dx.doi.org/10.3390/nu14051033] [PMID: 35268010]
[16]
Lai RH, Hsu CC, Yu BH, et al. Vitamin D supplementation worsens Alzheimer’s progression: Animal model and human cohort studies. Aging Cell 2022; 21(8): e13670.
[http://dx.doi.org/10.1111/acel.13670] [PMID: 35822270]
[17]
Lai RH, Hsu YY, Shie FS, Huang CC, Chen MH, Juang JL. Nongenomic rewiring of vitamin D receptor to p53 as a key to Alzheimer’s disease. Aging Cell 2021; 20(12): e13509.
[http://dx.doi.org/10.1111/acel.13509] [PMID: 34725922]
[18]
Kulda V. [Vitamin D metabolism] Vnitr Lek 2012; 58(5): 400-4. [Vitamin D metabolism].
[PMID: 22716179]
[19]
Jurutka PW, Thompson PD, Whitfield GK, et al. Molecular and functional comparison of 1,25-dihydroxyvitamin D3 and the novel vitamin D receptor ligand, lithocholic acid, in activating transcription of cytochrome P450 3A4. J Cell Biochem 2005; 94(5): 917-43.
[http://dx.doi.org/10.1002/jcb.20359] [PMID: 15578590]
[20]
Hua F, Reiss JI, Tang H, et al. Progesterone and low-dose vitamin D hormone treatment enhances sparing of memory following traumatic brain injury. Horm Behav 2012; 61(4): 642-51.
[http://dx.doi.org/10.1016/j.yhbeh.2012.02.017] [PMID: 22570859]
[21]
Duchaine CS, Talbot D, Nafti M, et al. Vitamin D status, cognitive decline and incident dementia: The Canadian Study of Health and Aging. Can J Public Health 2020; 111(3): 312-21.
[http://dx.doi.org/10.17269/s41997-019-00290-5] [PMID: 32016921]
[22]
Oveisgharan S, Arvanitakis Z, Yu L, Farfel J, Schneider JA, Bennett DA. Sex differences in Alzheimer’s disease and common neuropathologies of aging. Acta Neuropathol 2018; 136(6): 887-900.
[http://dx.doi.org/10.1007/s00401-018-1920-1] [PMID: 30334074]
[23]
Vieth R. Vitamin D supplementation: Cholecalciferol, calcifediol, and calcitriol. Eur J Clin Nutr 2020; 74(11): 1493-7.
[http://dx.doi.org/10.1038/s41430-020-0697-1] [PMID: 32704098]
[24]
Dawson-Hughes B. Vitamin D deficiency in adults: Definition, clinical manifestations, and treatment. 2022. Available from: https://www.uptodate.com/contents/vitamin-d-deficiency-in-adults-definition-clinical-manifestations-and-treatment
[25]
Bivona G, Lo Sasso B, Iacolino G, et al. Standardized measurement of circulating vitamin D [25(OH)D] and its putative role as a serum biomarker in Alzheimer’s disease and Parkinson’s disease. Clin Chim Acta 2019; 497: 82-7.
[http://dx.doi.org/10.1016/j.cca.2019.07.022] [PMID: 31330127]
[26]
Chen H, Xue W, Li J, et al. 25-Hydroxyvitamin D levels and the risk of dementia and alzheimer’s disease: A dose–response meta-analysis. Front Aging Neurosci 2018; 10: 368.
[http://dx.doi.org/10.3389/fnagi.2018.00368] [PMID: 30473663]
[27]
Davis M, O’Connell T, Johnson S, et al. Estimating Alzheimer’s disease progression rates from normal cognition through mild cognitive impairment and stages of dementia. Curr Alzheimer Res 2018; 15(8): 777-88.
[http://dx.doi.org/10.2174/1567205015666180119092427] [PMID: 29357799]
[28]
Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256(3): 183-94.
[http://dx.doi.org/10.1111/j.1365-2796.2004.01388.x] [PMID: 15324362]
[29]
Ouma S, Suenaga M. Bölükbaşı Hatip FF, Hatip-Al-Khatib I, Tsuboi Y, Matsunaga Y. Serum vitamin D in patients with mild cognitive impairment and Alzheimer’s disease. Brain Behav 2018; 8(3): e00936.
[http://dx.doi.org/10.1002/brb3.936] [PMID: 29541546]
[30]
Palanca A, Ampudia-Blasco FJ, Real JT. The controversial role of vitamin D in thyroid cancer prevention. Nutrients 2022; 14(13): 2593.
[http://dx.doi.org/10.3390/nu14132593] [PMID: 35807774]
[31]
Karampela I, Sakelliou A, Vallianou N, Christodoulatos GS, Magkos F, Dalamaga M. Vitamin D and Obesity: Current evidence and controversies. Curr Obes Rep 2021; 10(2): 162-80.
[http://dx.doi.org/10.1007/s13679-021-00433-1] [PMID: 33792853]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy